Or. Admin. R. 845-025-7080

Current through Register Vol. 63, No. 8, August 1, 2024

Section 845-025-7080 - Cannabinoid Topical Labeling Requirements

Prior to a cannabinoid topical product being sold or transferred to a consumer, patient or designated primary caregiver the container holding the cannabinoid product must have a label that has the following information:

(1) Processor's business or trade name and license number;

(2) Business or trade name of licensee that packaged the product, if different from the processor;

(3) UID number;

(4) Product identity;

(5) Date the product was made;

(6) Net weight or volume in U.S. customary and metric units;

(7) Amount suggested for use by the consumer or patient at any one time;

(8) Concentration of THC and CBD in the container (%);

(9) List of ingredients in descending order of predominance by weight or volume used to process the cannabinoid topical;

(10) Name of the lab that performed any test and any test analysis date;

(11) Universal symbol;

(12) A statement that reads: "This product is not approved by the FDA to treat, cure, or prevent any disease";

(13) For cannabinoid topicals for sale to a consumer, warnings that state:

(a) "For use only by adults 21 and older. Keep out of reach of children."

(b) "DO NOT EAT" in bold, capital letters.

Or. Admin. R. 845-025-7080

OLCC 6-2018, adopt filed 05/23/2018, effective 6/1/2018; OLCC 150-2022, minor correction filed 03/25/2022, effective 3/25/2022

Statutory/Other Authority: ORS 475C.604

Statutes/Other Implemented: ORS 475C.604